FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
 Re-authorization of the Pandemic and All-Hazards Preparedness Act
 NDAA - provisions related to biological and chemical defense
 Department of Defense appropriations for Medical Countermeasures
 FDA regulatory issues
 Issues related to Priority Review Voucher programs
 Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
 Re-authorization of the Pandemic and All-Hazards Preparedness Act
 NDAA - provisions related to biological and chemical defense
 Department of Defense appropriations for Medical Countermeasures
 FDA regulatory issues
 Issues related to Priority Review Voucher programs
 Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
 Re-authorization of the Pandemic and All-Hazards Preparedness Act
 NDAA - provisions related to biological and chemical defense
 Department of Defense appropriations for Medical Countermeasures
 FDA regulatory issues
 Issues related to Priority Review Voucher programs
 Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
DIS - Disaster Planning/Emergencies BUD - Budget/Appropriations HOM - Homeland Security
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
EMERGENT BIOSOLUTIONS INC.
1455 Pennsylvania Avenue, NW, SUITE 1225, Washington, DC, 20004, US
CHRIS FRECH JILL HAMAKER GRANT BARBOSA KATHERINE GETTY CHRIS FRECH JILL HAMAKER GRANT BARBOSA KATHERINE GETTY CHRIS FRECH JILL HAMAKER GRANT BARBOSA KATHERINE GETTY